Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.05 GBP per share
-
Shares outstanding
-
84,213,667
-
Total 13F shares
-
6,984,029
-
Share change
-
+1,134,350
-
Total reported value
-
$28,790,000
-
Price per share
-
$4.12
-
Number of holders
-
14
-
Value change
-
+$4,644,284
-
Number of buys
-
4
-
Number of sells
-
6
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q1 2020
As of 31 Mar 2020 Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) had 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,984,029 shares of stock of the company.
Largest 10 holders included Vivo Capital, LLC, ORBIMED ADVISORS LLC, NEA Management Company, LLC, Abingworth LLP, Novo Holdings A/S, venBio Partners LLC, Aisling Capital Management LP, Tekla Capital Management LLC, D.A. DAVIDSON & CO., and WEDBUSH SECURITIES INC.
This table shows 14 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.